Sunday, October 11, 2026
ExploreSearch
Via News
Markets

NIO Stock Bullish Momentum With A 2.77% Rise on Thursday

ViaNews Editorial Team

December 10, 2020

NIO Stock Bullish Momentum With A 2.77% Rise on Thursday
The New York Stock Exchange ended the session with NIO jumping 2.77% to $45.23 on Thursday, following yesterday's downward trend. The New York Stock Exchange jumped 0.14% to $14,394.30, following yesterday's downward trend on what was a somewhat positive trend trading session today. NIO today's close was $45.23, 26.46% below its 52-week high of $57.20.

NIO's Sales

NIO's sales growth is 138.2% for the present quarter and 264.6% for the next. The company's growth estimates for the present quarter and the next is 74.4% and 47.8%, respectively.

NIO's Stock Top and Bottom Yearly Value

NIO's stock is valued at $45.23 at 18:06 EST, way under its 52-week high of $57.20 and way above its 52-week low of $2.11.

NIO's Moving Average

NIO's worth is above its 50-day moving average of $41.67 and way above its 200-day moving average of $21.11.

Categories

Markets

Tags

Stock MarketStockWall StreetStock PriceStock Market NowNYSEMarket SessionNYAThe New York Stock ExchangeNIOStock Price Up
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com